pharma news

News

Sanofi grabs Chinese rights to Arrowhead rare disease drug

Sanofi has paid $130 million upfront for Chinese rights to an Arrowhead Pharma drug for rare disease familial chylomicronaemia syndrome.

News

Lilly trumpets heart health data with Mounjaro

Eli Lilly has raised the stakes in its rivalry with Novo Nordisk on GLP-1 drugs for diabetes, with new data for Mounjaro on cardiovascular outcomes.

News

Google wearable AI can 'learn the language of our bodies'

Google unveils a new family of sensor–language foundation models that could underpin a new generation of smarter health wearables.

News

Is AbbVie planning an epic Gilgamesh takeover?

AbbVie could be heading for its second acquisition in the space of a month, as rumours emerge of a $1bn bid for psychiatric drug developer Gilgamesh.

News

Tidmarsh to stand in for Prasad's role at CBER

Following Vinay Prasad's abrupt departure as CBER director, FDA has asked CDER head George Tidmarsh to take on both roles while a successor is sought.

News

NICE CEO to step down by year-end

Sam Roberts is stepping down from the role of NICE CEO to support her children through a difficult time, and a search for her replacement is underway.

Sanofi grabs Chinese rights to Arrowhead rare disease drug

Lilly trumpets heart health data with Mounjaro

Google wearable AI can 'learn the language of our bodies'

Is AbbVie planning an epic Gilgamesh takeover?

Tidmarsh to stand in for Prasad's role at CBER

NICE CEO to step down by year-end

LSX2026: Addressing adult eye cancer, with Roi Raz

Using AI-driven synthetic personas to take your insights fur...

pharma news

Editor's Picks